{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:16:36Z","timestamp":1790975796063,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Migraines are a chronic disease for millions worldwide and have been hypothesized to be hormonally mediated due to their higher prevalence in females and menstrual associations. Estrogen has been commonly implicated in migraine pathogenesis, yet its exact role in the pathophysiology of migraines has yet to be fully understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>We conducted a scoping review of the literature regarding estrogen\u2019s role in migraine pathogenesis and included 19 studies out of an initial 202 in the final review. Two independent reviewers screened and extracted data from included studies based on predetermined inclusions and exclusion criteria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The estrogen withdrawal hypothesis, discussed by 12 of the reviewed studies, is the most discussed theory about estrogen\u2019s role in migraine physiology and describes the association of migraine onset with natural declines in estrogen levels, particularly when estrogen levels fall below 45\u201350 pg\/mL after an extended period of priming. Additional findings suggest that women with a history of migraine have an increased sensitivity to physiologic fluctuations in estradiol levels. Several studies suggest that migraines are associated with menstruation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>It appears that estrogen is very likely to play a key role in migraine pathogenesis, but seems to affect patients in different ways depending on their past medical history, age, and use of hormonal therapy. Further research is warranted to isolate the effects of estrogen in each unique patient population, and we believe that studies comparing menstruating women to postmenopausal women could help shed light in this area.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13643-021-01618-4","type":"journal-article","created":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T18:03:04Z","timestamp":1615399384000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["The complex relationship between estrogen and migraines: a scoping review"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4945-3396","authenticated-orcid":false,"given":"Nihaal","family":"Reddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miraj N.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Schoenbrunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Schneeberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey E.","family":"Janis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,10]]},"reference":[{"issue":"4","key":"1618_CR1","first-page":"835","volume":"18","author":"JL Brandes","year":"2012","unstructured":"Brandes JL. Migraine in women. CONTINUUM: Lifelong Learning in Neurology. Headache. 2012;18(4):835\u201352.","journal-title":"Headache"},{"key":"1618_CR2","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.maturitas.2009.06.004","volume":"4","author":"BE Cairns","year":"2009","unstructured":"Cairns BE, Gazerani P. Sex-related differences in pain. Maturitas. 2009;4:292.","journal-title":"Maturitas"},{"key":"1618_CR3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/OGX.0000000000000540","volume":"3","author":"ET Bushman","year":"2018","unstructured":"Bushman ET, Varner MW, Digre KB. Headaches through a woman\u2019s life. Author abstract. Obstet Gynecol Surv. 2018;3:161. https:\/\/doi.org\/10.1097\/OGX.0000000000000540.","journal-title":"Obstet Gynecol Surv"},{"key":"1618_CR4","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1111\/j.1526-4610.2008.01176.x","volume":"8","author":"A Calhoun","year":"2008","unstructured":"Calhoun A, Ford S. Elimination of menstrual-related migraine beneficially impacts chronification and medication overuse. Headache. 2008;8:1186.","journal-title":"Headache"},{"key":"1618_CR5","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1001\/jama.295.15.1824","volume":"15","author":"JL Brandes","year":"2006","unstructured":"Brandes JL. The influence of estrogen on migraine: a systematic review. JAMA. 2006;15:1824.","journal-title":"JAMA"},{"issue":"3","key":"1618_CR6","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1212\/01.WNL.0000130338.62037.CC","volume":"63","author":"T Pringsheim","year":"2004","unstructured":"Pringsheim T, Gooren L. Migraine prevalence in male to female transsexuals on hormone therapy. Neurology. 2004;63(3):593\u20134. https:\/\/doi.org\/10.1212\/01.WNL.0000130338.62037.CC.","journal-title":"Neurology"},{"key":"1618_CR7","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0010-7824(93)80141-H","volume":"48","author":"AC Cachrimanidou","year":"1993","unstructured":"Cachrimanidou AC, Hellberg D, Nilsson S, Waldenstr\u00f6m U, Olsson SE, Sikstr\u00f6m B. Long-interval treatment regimen with a desogestrel-containing oral contraceptive. Contraception. 1993;48:205\u201316 (0010-7824 (Print))doi: D - PIP: 090231D - POP: 00226696 OTO \u2013 PIP.","journal-title":"Contraception"},{"key":"1618_CR8","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1089\/154099903322643956","volume":"12","author":"AL Misakian","year":"2003","unstructured":"Misakian AL, Langer RD, Bensenor IM, et al. Postmenopausal hormone therapy and migraine headache. J Womens Health. 2003;12:1027\u201336 (1540-9996 (Print)).","journal-title":"J Womens Health"},{"key":"1618_CR9","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1526-4610.2005.05047.x","volume":"45","author":"BY Amir","year":"2005","unstructured":"Amir BY, Yaacov B, Guy B, Gad P, Itzhak W, Gal I. Headaches in women undergoing in vitro fertilization and embryo-transfer treatment. Headache. 2005;45:215\u20139 (0017-8748 (Print)).","journal-title":"Headache"},{"issue":"6561","key":"1618_CR10","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1136\/bmj.293.6561.1540","volume":"293","author":"BD Lignieres","year":"1986","unstructured":"Lignieres BD, Vincens M, Mauvais-Jarvis P, Mas JL, Touboul PJ, Bousser MG. Prevention of menstrual migraine by percutaneous oestradiol. research-article. Brit Med J. 1986;293(6561):1540.","journal-title":"Brit Med J"},{"issue":"9","key":"1618_CR11","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1046\/j.1526-4610.2002.02215.x","volume":"42","author":"F Facchinetti","year":"2002","unstructured":"Facchinetti F, Nappi RE, Tirelli A, Polatti F, Nappi G. Hormone supplementation differently affects migraine in postmenopausal women. Headache. 2002;42(9):924\u20139. https:\/\/doi.org\/10.1046\/j.1526-4610.2002.02215.x.","journal-title":"Headache"},{"key":"1618_CR12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1046\/j.1526-4610.2003.03065.x","volume":"43","author":"V Martin","year":"2003","unstructured":"Martin V, Wernke S, Mandell K, Zoma W, et al. Medical oophorectomy with and without estrogen add-back therapy in the prevention of migraine headache. Headache. 2003;43:309\u201321 (0017-8748 (Print)).","journal-title":"Headache"},{"issue":"12","key":"1618_CR13","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1212\/01.wnl.0000249114.52802.55","volume":"67","author":"EA MacGregor","year":"2006","unstructured":"MacGregor EA, Frith A, Ellis J, Aspinall L, Hackshaw A. Prevention of menstrual attacks of migraine: a double-blind placebo-controlled crossover study. Neurology. 2006;67(12):2159\u201363. https:\/\/doi.org\/10.1212\/01.wnl.0000249114.52802.55.","journal-title":"Neurology"},{"key":"1618_CR14","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1097\/01.SMJ.0000129924.15619.D9","volume":"97","author":"AH Calhoun","year":"2004","unstructured":"Calhoun AH. A novel specific prophylaxis for menstrual-associated migraine. South Med J. 2004;97:819\u201322 (0038-4348 (Print)).","journal-title":"South Med J"},{"key":"1618_CR15","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1212\/WNL.45.6.1076","volume":"45","author":"CB Johannes","year":"1995","unstructured":"Johannes CB, Linet MS, Stewart WF, Celentano DD, Lipton RB, Szklo M. Relationship of headache to phase of the menstrual cycle among young women: a daily diary study. Neurology. 1995;45:1076\u201382 (0028-3878 (Print)).","journal-title":"Neurology"},{"issue":"4","key":"1618_CR16","first-page":"313","volume":"6","author":"EM Lichten","year":"1995","unstructured":"Lichten EM, Lichten JB, Whitty AJ, Pieper D. The use of leuprolide acetate in the diagnosis and treatment of menstrual migraine - the role of artificially-induced menopause. Headache Quart Curr Treat Res. 1995;6(4):313\u20137.","journal-title":"Headache Quart Curr Treat Res"},{"key":"1618_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1046\/j.1526-4610.2003.03005.x","volume":"43","author":"P Mattsson","year":"2003","unstructured":"Mattsson P. Hormonal factors in migraine: a population-based study of women aged 40 to 74 years. Headache. 2003;43:27\u201335 (0017-8748 (Print)).","journal-title":"Headache"},{"key":"1618_CR18","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1212\/WNL.55.10.1517","volume":"55","author":"WF Stewart","year":"2000","unstructured":"Stewart WF, Lipton RB, Chee E, Sawyer J, Silberstein SD. Menstrual cycle and headache in a population sample of migraineurs. Neurology. 2000;55:1517\u201323 (0028-3878 (Print)).","journal-title":"Neurology"},{"issue":"6","key":"1618_CR19","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1046\/j.1526-4610.1996.3606367.x","volume":"36","author":"JB Lichten","year":"1996","unstructured":"Lichten JB, Whitty A, Pieper D, Lichten EM. The confirmation of a biochemical marker for women\u2019s hormonal migraine: The depo-estradiol challenge test. Headache. 1996;36(6):367\u201371. https:\/\/doi.org\/10.1046\/j.1526-4610.1996.3606367.x.","journal-title":"Headache"},{"issue":"9","key":"1618_CR20","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1046\/j.1526-4610.1999.3909625.x","volume":"39","author":"DA Marcus","year":"1999","unstructured":"Marcus DA, Scharff L, Turk D. Longitudinal prospective study of headache during pregnancy and postpartum. Headache. 1999;39(9):625\u201332. https:\/\/doi.org\/10.1046\/j.1526-4610.1999.3909625.x.","journal-title":"Headache"},{"key":"1618_CR21","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/S0015-0282(97)81928-0","volume":"67","author":"SC Murray","year":"1997","unstructured":"Murray SC, Muse KN. Effective treatment of severe menstrual migraine headaches with gonadotropin-releasing hormone agonist and \u201cadd-back\u201d therapy. Fertil Steril. 1997;67:390\u20133 (0015-0282 (Print)).","journal-title":"Fertil Steril"},{"issue":"4","key":"1618_CR22","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1212\/WNL.22.4.355","volume":"22","author":"BW Somerville","year":"1972","unstructured":"Somerville BW. The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology. 1972;22(4):355\u201365. https:\/\/doi.org\/10.1212\/WNL.22.4.355.","journal-title":"Neurology"},{"key":"1618_CR23","doi-asserted-by":"publisher","first-page":"S190","DOI":"10.1007\/s10072-006-0599-6","volume":"27","author":"KMA Welch","year":"2006","unstructured":"Welch KMA, Brandes JL, Berman NEJ. Mismatch in how oestrogen modulates molecular and neuronal function may explain menstrual migraine. Neurol Sci. 2006;27:S190\u20132.","journal-title":"Neurol Sci"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-021-01618-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13643-021-01618-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-021-01618-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T18:03:13Z","timestamp":1615399393000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-021-01618-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,10]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1618"],"URL":"https:\/\/doi.org\/10.1186\/s13643-021-01618-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-102005\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-102005\/v2","asserted-by":"object"}]},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,10]]},"assertion":[{"value":"1 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Janis received royalties from Thieme and Springer publishing and is a consultant for LifeCell\/Allergan. The remaining authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"72"}}